MTOR and Hyperglycemia: Inhibition of mTOR signaling using rapalogs, including rapamycin produces debilitating and serious side-effects such as rash, anemia, fatigue, hyperglycemia, decreased appetite, nausea, and diarrhea (Pallet and Legendre, 2013).